|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/451 | |
| A61K 31/58 | |||
| A61K 9/00 | |||
| A61K 9/10 | |||
| A61K 47/38 | |||
| A61K 47/26 | |||
| A61P 11/02 | |||
| A61P 27/14 |
| (11) | Patento numeris | 2931249 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13803046.5 |
| Europos patento paraiškos padavimo data | 2013-12-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-01-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/076486 |
| Data | 2013-12-13 |
| (87) | Numeris | WO 2014/095602 |
| Data | 2014-06-26 |
| (30) | Numeris | Data | Šalis |
| 201261737927 P | 2012-12-17 | US | |
| 201361867794 P | 2013-08-20 | US |
| (72) |
IGNAR, Diane Michele, US
LEVIN, Daren Scott, US
|
| (73) |
Glaxo Group Limited,
980 Great West Road Brentford, Middlesex TW8 9GS,
GB
|
| (54) | COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS |
| COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS |